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ADVANCING HEALTH CARE
Volunteers are needed for a National Lung Screening Trial to
compare the effectiveness of spiral computed tomography
(CT) scans and chest X rays in detecting lung cancer. David
Gierada, MD, assistant professor of radiology, is principal investigator for this two-year clinical trial, which is sponsored by the
National Cancer Institute and Washington University School of
Medicine.
If you meet the following criteria, you may be one of the 6,000
patients eligible to participate in this important study.
I Man or woman between the ages of 55 and 74.
I Have a history of longtime and/or heavy cigarette smoking,
for example
• At least 1 pack/day for at least 30 years
• 1 'A packs/day for at least 20 years
• 2 packs/day for at least 15 years
• 2 lk packs/day for at least 12 years
• 3 packs/day for at least 10 years.
e Currently a smoker or have quit smoking within the
last 10 years.
i Have NOT been diagnosed with lung cancer.
i NOT undergoing treatment for any cancer other than
non-melanoma skin cancer.
K

Have NOT had any portion of your lung removed.

■ Not participating in a cancer prevention trial, other than a
smoking cessation program.
■ Not participating in another cancer screening trial,
including PLCO.
Participants will receive 3 annual screening exams (either
spiral CT or chest X ray). There is no charge for the exams.
Validated parking is available for each visit.
Call the Volunteer for Health Office at (314) 362-1000
to see if you are eligible to participate.
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EXPANDING SOUND
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Cochlear implants have restored hearing
for thousands of patients, but no technology has been available to image the
implant's insertion depth—which determines the extent of hearing gained.
Researchers at MIR and in the Department
of Otolaryngology now are using computed
tomography and new imaging techniques
to expand sound.

WHEN BREAST CANCER RECURS
Hyperthermia is a decades-old treatment for many types
of malignant tumors. Clinicians and physicists in the
Department of Radiation Oncology are now investigating
the benefits of using hyperthermia and radiation simultaneously to treat patients with recurrent breast cancer.
A VISION FOR THE FUTURE: MOLECULAR IMAGING
In the postgenomic future, most anatomic disease may
no longer exist as a result of early detection at the molecular level. And Mallinckrodt Institute will be in the
forefront of this future medical care thanks to its Molecular Imaging Center now being established at MIR.
RADIOLOGY AT THE WINTER OLYMPICS

SPOT NEWS

With more than 2,500 participating athletes, the 2002
Winter Olympics in Salt Lake City was the largest of the
winter games ever held. A Mallinckrodt Institute radiologist was on staff at the Olympic Polyclinic, providing
health care for athletes from 77 countries.
EMERGENCY AND TRAUMA CENTER:
A CONVENIENT, MORE PRIVATE FACILITY

24

FYI

More than 80,000 patients annually receive emergency or
trauma care at Washington University Medical Center.
The new Charles F. Knight Emergency and Trauma
Center can provide urgent, emergent, and trauma/critical
care as well as observation in one convenient location.

ON THE COVER Researchers Bruce Whiting, PhD, and Margaret Skinner, PhD, are using
the Somatom Plus 4 Volume Zoom computed tomography (CT) scanner in their cochlear
implant study. This machine has multirow detectors that help produce high-resolution
scans. Photograph by Tim Parker.
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Picus elected
to FPP Board
Daniel Picus, MD, professor of radiology and of
surgery and director of the
Division of Diagnostic Radiology, was elected in January to
a three-year term on the
Washington University School
of Medicine (WUSM) Faculty
Practice Plan (FPP) Board of
Directors. He is one of six faculty-at-large representatives
on the Board, all of whom are
selected based on ballots submitted by the WUSM full-time
clinical faculty.
The FPP was established in 1997 to manage the
medical school's clinical
operations, with responsibility in the areas of clinical
oversight, administration, fiscal management, and clinical
planning. Marilyn Siegel,
MD, professor of radiology
and of pediatrics, was one of
the first faculty representatives on a then-13 member
Board. She was appointed to
an initial two-year term and
asked to remain for an additional three-year term, which
was completed in January
2002. The FPP Board is now
comprised of 30 members
and includes the heads of
WUSM's clinical departments. Gilbert Jost, MD, professor of radiology and head
of Mallinckrodt Institute,
represents the Department
of Radiology.

fASF RFVIFW
General and
Vascular
Ultrasound

Middleton
authors second
sonography
reference
Case Review: General
and Vascular Ultrasound,
written by William Middleton, MD, professor of radiology, is one of 14 volumes
included in the Case Review
series published by Mosby
Inc. The 242-page book
includes 211 cases that are
divided according to complexity and range from
gallbladder sludge to intrahepatic biliary ductal dilation, from tumor thrombus of
the renal vein and inferior
vena cava to muscle tear and
hematoma. The book contains 440 general and vascular ultrasound images,
including 84 color plates.

Middleton selected and
scanned cases representative
of material typically used for
board examinations. Cases
are presented in a questionand-answer format that
allows readers to assess
their proficiencyin each subspecialty. According to Middleton, his goal is "to provide
an affordable, useful, and
enjoyable learning tool for
sonographers, residents, and
practicing physicians."
The Case Review series
cross-references Mosby's
The Requisites™ series, for
which Middleton coauthored
a volume titled Ultrasound:
The Requisites.

Gado named
outstanding
educator
Washington University
School of Medicine students
annually honor those faculty
members who possess the
attributes of an outstanding
teacher: creativity, organization, knowledge, compassion, energy, and dedication.
Mokhtar Gado, MD, professor of radiology, was among
those honored at the Distinguished Service Teaching
Awards ceremony held in
January at the Eric P. Newman Education Center on
the Washington University
Medical Center campus.

Gado came to Mallinck
rodt Institute in 1970 as an
instructor in radiology and
was appointed chief of neuroradiology in 1971. He was
named professor of radiology in 1976. Gado stepped
down as neuroradiology
chief in 1991 to devote more
time to clinical and research
activities. He is internationally known for his studies of
Alzheimer's disease, cerebrovascular disease, and
depression.
Gado directed the neuroradiology fellowship training program at the Institute
from 1971 to 1998, and in
1996, he was elected by the
diagnostic radiology residents as Mallinckrodt Institute's Teacher of the Year.
He is a fellow of the American College of Radiology
and past vice-president of
the American Society of
Neuroradiology. Gado has
served as a reviewer or as an
editorial board member for
several medical journals.
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Monsees

WUSM ranked
third in nation

Barbara Monsees, MD,
professor of radiology and
chief of breast imaging, was
recognized by the American
Cancer Society (ACS) as a
national leader in the field of
breast imaging. In March,
Monsees was one of the
recipients of the St. Louis
Spirit of Health Recognition
award, which is sponsored
by the ACS Heritage League
Founders and Ortho
Biotech.
Monsees is a nationally known advocate of the
early detection of breast
cancer through mammography and of affordable,
accessible, high-quality
breast imaging services.
She recently completed a
four-year term as chair of
the FDA's Quality Assurance Advisory Committee
for the National Mammography Quality Standards
Act and is the current president of the Society of
Breast Imaging.

The fifteenth annual survey of graduate and professional programs conducted
by U. S. News & World
Report magazine lists Washington University School of
Medicine in St. Louis as the
third top-ranked medical
school in the nation, following Harvard University and
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biology, neurosciences,
pediatrics, women's health
program, and pharmacology/
toxicology.
The magazine's survey
of Honor Roll hospitals
ranked Barnes-Jewish Hospital in a tie for seventh place
with the University of
Michigan Medical Center.

Johns Hopkins University.
In 2001, WUSM tied with the
University of Pennsylvania
for fourth place. WUSM's
physical therapy program
retained its perennial firstplace ranking. Other WUSM
specialties and programs in
the top-ten list are the AIDS
program, occupational therapy, internal medicine, cell
biology, the drug/alcohol
abuse program, genetics,
microbiology, molecular
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„i between
the departments of Radiology
and Otolaryngology is helping
to create sounds from silence
for patients with hearing loss.
Willm»Mtf:HMS«SKlCKI

"housands of profoundly deaf men, women,
and children have received an implanted
device that permits them to hear carefully spoken speech, a honking car horn, and sounds
such as a baby's wail. Now, Bruce Whiting,
PhD, research assistant professor of radiology,
and his colleagues at Mallinckrodt Institute of
Radiology (MIR) and the Department of Otolaryngology at Washington University School of
Medicine want to expand the sound experience
of cochlear implant recipients even further.

by BARBRA RODRIGUEZ

More than 40,000 people
worldwide, some as young as one
year, have received a cochlear
implant: a sound-receiving device
and a series of electrodes
implanted into the head that
transfers sounds processed by a
portable device as an electrical
signal to the auditory nerve of the
inner ear. Some patients have
received a cochlear implant
because of trauma to ear structures, such as delicate hair cells
that transmit sound information
or because of complications from
diabetes, Meniere's disease, or otosclerosis (the development of bony
growths in the inner ear). And
other patients, as they age, simply
no longer benefit from the most
powerful hearing aids.
Using the implants, more than
half of the patients can hear about
80 percent of the words in recordings of well-articulated, easy sentences, such as the test developed
at Central Institute for the Deaf at
Washington University Medical
Center. Phone conversations or
other sounds may still be difficult
though, be it a whispered aside
between friends, the comments of
a loved one watching television in
the next room, or a hushed passage of a Beethoven symphony.

Opposite page: 1) Computed tomography (CT) slice.
2) Two-dimensional X ray of patient with cochlear
implant. 3) Computed tomography overlay on
two-dimensional X ray. Illustrates coregistration
of projected CT voxels (grey) onto CR pixels (white).
4) Two-dimensional X ray backprojected to threedimensional CT image.
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Imaging roadblocks
How deeply a hearing implant's
thin strand of electrodes is placed
into a patient's inner ear was
thought to influence the extent of
hearing ability gained. But no one
knew for certain where each electrode was in the cochlea after
surgery because no adequate diagnostic imaging techniques existed.
Conventional radiographs did not
provide enough three-dimensional
information about anatomy, while
cross-section modalities (CT, MRI)
blurred individual array elements.
"The electrode insertion is done
blind," says Margaret Skinner, PhD,
professor of otolaryngology and
director of the School of Medicine's
cochlear implant program.
In the 1990s, Skinner teamed
up with Mallinckrodt Institute
imaging specialists and researchers
across the country to improve
imaging of cochlear implants in the
inner ear. Whiting began directing
the current imaging project soon
after coming to Mallinckrodt Institute in 1997 from industrial positions where he had worked on
computed radiography and other
medical imaging technology. "With
Bruce's input, we're trying to push
the limits of imaging technology to
the max," Skinner says.

IUCTROOC ARRAY

The basic components of a cochlear implant.

Semicircular canals
Vesllbular nerve

Cochlear nerve
Eustachlantube
(outer ear)

The external, middle, and inner ear.
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The bionicear
Components of the ear normally turn sound waves into vibrations within fluid-filled channels of
the spiraling, snail-shaped cochlea.
Jutting into one channel are cells
whose surface is dotted with hairs.
Just as seaweed bends in response
to a passing wave, the hairs are
indirectly bent by the passing vibrational waves, which stimulates the
cells to activate nearby auditory
neurons.

/
/

MIR research
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Todd Gebke, RT(R), assisted Skinner in setting up
the cochleor implant studies.

A cochlear-implant user wears
an external microphone and a battery-powered speech processor,
which groups incoming sounds of
similar pitches together. The packets
of electrical sound information, or
filter bands, are sent to a receiver
implanted under the skin of the
patient's skull. The receiver relays
the signals to the electrodes
threaded into one of the cochlea's
channels, which excite auditory neurons lying beneath the channel wall.
Selected pitches, or frequencies, of sound are sent to different
electrodes because neurons along
the cochlea's length usually
respond to different pitches. For
example, the vowel in the word
"caught" is loaded with lowerpitched sounds that normally create vibrational waves further into
the cochlea. An implant recipient
whose electrodes only extend
halfway into the cochlea may thus
receive this lower-pitched information at the wrong neurons.

To determine if insertion depth
influences hearing ability, Whiting
joined an imaging project initially
begun by Kyongtae Bae, MD, PhD,
assistant professor of radiology.
The study involved patients who
had a 22-electrode array implant,
manufactured by Cochlear Corporation, that could deliver digital
speech information to 22 areas
within the cochlea.
Bae was testing the possibility
of visualizing the implants by combining the high spatial resolution
information of computed radiography (CR) with the improved 3-D
positional information of computed
tomography (CT). This combination
required precise positioning of a
patient's head so the central ray in
the radiograph was aligned to the
long axis of the spiral cochlea—
which was accomplished under the
guidance of Franz Wippold, MD,
associate professor of radiology
and chief of MIR's neuroradiology
section, and with expert assistance
from radiology technologists. CT
scans were performed with a
patient's head positioned so image
slices were orthogonal to the
cochlear axis. To align the images,
Bae attached six metal spheres to
each volunteer's face to identify the
same positions on each image.
Whiting modeled this' approach
using computer algorithms and
revealed that any movement of the
reference spheres between scans
would throw off the alignment
process. "If the alignment was off
by just fractions of a millimeter,"
Whiting says, "then the alignment
could be off by centimeters when
we mapped back to the head."

He suggested using the irregularly shaped implant receiver and
electrode wires as reference
objects to provide about 50,000
comparative points between the
images. An algorithm to determine
alignment transformation was
developed, and more than a year's
effort permitted the relative position of implants in the cochlear
channel to be determined for a
dozen patients, as reported in the
November 2001 issue of the journal
Radiology. "We were able to take
these three-dimensional structures
that were visible on the CT scan
but not on the X ray and superimpose them," Whiting says.
The coregistered CR and CT
information helped Skinner determine that insertion depth mattered.
When some electrodes could not be
inserted into a patient's cochlea,
the speech processor was programmed so no sound information
was delivered on those electrodes.
Meanwhile, the processor sent the
remaining, inserted electrodes mismatched pitch information, or frequency bands.
"As it turns out, frequency
band assignment is a very important factor in a patient's speech
recognition," Skinner says. "The
better the match between the characteristic frequencies for the neurons and the bands they set, the
faster a patient is going to learn
and understand speech."

MALLINCKRODT INSTITUTE OF RADIOLOGY

Those patients who had the full
array inserted, for example, often
achieved close to 100 percent word
recognition of pre-recorded sentences. But a woman with a narrow
cochlear canal, or other patients
who had less than half an array
inserted because of a short cochlea
or disease-related channel damage,
faired much worse.
Other implant recipients eventually achieved the 80 percent word
recognition despite having as little
as half of an electrode array
inserted, suggesting, as Skinner
notes, that mentally astute people
with few factors to hinder sound
recognition can mentally adapt to a
moderate extent of pitch mismatch.
The image coregistration
process also allowed the investigators to visualize when an electrode
strand was kinked or constricted,
which disrupted the affected electrode's function. Such information
should allow audiologists in the
future to improve an implant user's
hearing by parceling out sound
information to the remaining
electrodes.
In 2000, Barnes-Jewish Hospital purchased a Somatom Plus 4
Volume Zoom scanner, based on
new, multirow CT technology. The
CT scanner, manufactured by
Siemens, has four rows of X-ray
detectors, which permit scans to
cover about four times more volume in a given time. The device
also has a high-resolution mode,
with upwards of twice the resolving power of previous helical scanners. Evaluations indicated the
hearing researchers can locate individual electrodes that previously
were a blur on CT scans.

FOCAL SPOT, SPRING 2002

Further research
About 20 patients who have
newer versions of cochlear
implants have been scanned this
past year on the Volume Zoom
scanner with great success. But
Whiting, Skinner, and their colleagues are not satisfied that everything has been done to improve the
benefit of implants. Whiting is in
the third year of a grant from The
Whitaker Foundation to enhance
the Volume Zoom imaging information even further. In part, the work
involves constructing mathematical
models that predict the physics of
CT data acquisition. The goal:
removing imaging artifacts created
by radiodense electrodes and other
metal implant components.
These components produce
stark white regions on CT images
that obliterate underlying details in
the same way that sunlight
reflected into a rearview mirror
masks part of the image. Whiting is
addressing the issue, using statistical reconstruction algorithms
developed by Washington University colleagues Joseph O'Sullivan,
PhD, professor of electrical engineering and of radiology; Donald
Snyder, PhD, professor of electrical
engineering and of radiology; and
David Politte, PhD, research
instructor in radiology.

widespread use of
cochlear implants
Count Alessandro Volta, a
pioneer in electrochemistry,
developed the electrolytic cell
and attempted to determine
what effect electric current had
on sensory systems.

Organized studies are conducted
to determine whether stimulation
of the auditory nerve could result
in the sensation of hearing in
humans.

Researchers observed that
activation of the auditory nerve
with an electrical device provided
auditory stimulation in humans.
This observation paved the way
for cochlear implants.

Cochlear implant was developed
and tested in labs in Australia.

Cochlear implant was developed
and tested in the United States.

U.S. Food and Drug Administration approved the 3M/House
single-channel cochlear implant
as first device to replace a
human sense.

FDA approved the 22-channel
Nucleus cochlear implant for
use in children between the ages
of 2 and 17.

/

g's expertise in medical imaging
has been beneficial in evaluating
cochlear implants.
Bottom: Skinner and Tom Renaud, RT(R), monitor the positioning of a patient in the CT scanner.

Specifically, Whiting has created a 3-D model of the ideal CT
acquisition process—how X rays
would pass through an implant and
reach the Volume Zoom
detectors with attendant distortions. He then compares
the implant's estimated signal and actual signal and corrects for inconsistencies on
the reconstructed image.
The process works well,
although Whiting has a few
remaining distortions to
remove. He also intends to
shorten the hour-long computational process to make
the approach more clinically
relevant.
The improved images
from this 3-D modeling effort
also have allowed the implant
researchers to better visualize the exact position of each
0.5-mm wide electrode within
the cochlear channel. Using
image registration algorithms
developed by Barry Brunsden, research engineer in
MIR's electronic radiology
laboratory, surgeons can now
do preimplant and postimplant imaging and learn about
bone damage that can affect
surgical implantation.
The sharper images also have
given the hearing researchers a better understanding of where
implanted electrodes rest within
the cochlear channel, which will
aid in enhancing the implant's benefits. An electrode's position within
the scala tympani channel of the
cochlea influences hearing. An
electrode resting far from the neurons requires more current,
whereas a closer electrode requires
less current to cause a sensation of
hearing. A patient needs just the
right amount of current to each
electrode to hear sound with the
least distortion.

Skinner and Whiting have
begun sending the electrode positional information to Charles Finley, PhD, associate professor of
otolaryngology, at the University of
North Carolina School of Medicine.
Finley's estimates of the electrical
field produced around each electrode will be used to model the
anticipated effect on nearby auditory and other neurons. That
knowledge will be combined with
additional information about the
functional status of a patient's auditory neurons.
Altogether, the imaging information, electrical field monitoring,
hearing tests, and other efforts of
the clinicians, scientists, and engineers should permit more effective
programming of a patient's sound
processors. The efforts may also
provide the informational impetus
to convince cochlear implant manufacturers to develop more tailored
models for patients with different
circumstances. "The imaging effort
is just a piece of the picture," Whiting says. "It's an important part of
the research, but I believe there's a
wealth of other activities that are
going to be based on the imaging,
which eventually will lead to better
patient outcomes."
Applying his computational
background to a project that links
technology to patient care already
has been rewarding, Whiting adds.
"It's very satisfying to translate
these new technical ideas into
something that has real life benefits," he says, ma
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AND PHYSICISTS
GATING
THE BENEFITS
OF USING HEAT
AND RADIATION

TO DESTROY
CANCER CELLS.

BY CHRIS WAYLAND

cancer

'HO HAS HAD A MASTECTOMY FOLLOWING A DIAGNOSIS OF

WOMAN

I, THE TUMOR IS GONE BUT THE RISK OF RECURRENCE
REMAINS IF CANCEROUS CELLS ARE PRESENT IN THE CHEST WALL. HEATINDUCED RADIOSENSITIZATION IS KEY TO ATTACKING THIS NONVISIBLE CANCER, SAYS ROBERT MYERSON, PHD, MD, CLINICAL CHIEF OF HYPERTHERMIA AT

woman

IENT OF RADIATION ONCOLOGY.

MYERSON IS THE PRINCIPAL INVESTIGATOR FOR A NATIONAL INSTITUTES
• HEALTH/NATIONAL INSTITUTE OF
.NCER-FUNDED CLINICAL STUDY OF
THE LONG-TERM EFFECTS OF SIMULTANEOUSLY TREATING RECURRENT
BREAST CANCER WITH HEAT TREAT-

SURLAS protoype used in laboratory studies.

HYPERTHERMI

MENTS, KNO
AND RADIATION

ID DELfVERS THE H.

CANCER CELLS TO A TEMPERATURE OF 41°C GUST BELOW 106°F) AND MAKING
THE CELLS MORE RECEPTIVE TO RADIATION. THE RESULT? MC

CANCEROUS

DESTROYED BY THIS DUAL THERAPY THAN WHEN RADIA
) ALONE. THE NUMBER OF TREATMENTS GrVEN, THE TIMING OF THE
HYPERTHERMIA, AN

TECHNOLOGY

>ED TO DELIVER THE TREATMENTS
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Robert Myerson, PhD, MD

' e know that mild
temperatures of heat
given at the same
time as radiation can
markedly enhance the ability of
radiation to kill cancer cells. It's
very important that the radiation
and the heat be given at the same
time," says Myerson. "If a patient
receives the heat and then ten minutes elapse before she is given the
radiation treatment, the radiation
enhancement is much, much less."
By itself, 41°C would not kill
any cancer cells or normal cells
unless the temperature was maintained for an extremely long time,
Myerson says, adding that hyperthermia would only be given for an
hour. But an hour is long enough to
interfere with the ability of the
cells to repair themselves from the
effects of radiation.
Since hyperthermia is delivered at either 41°C or 42°C, heating
the entire target area consistently
makes the synergistic effect with
the radiation work best. Temperature monitors track the heat at
eight tol2 points on the skin of the
chest wall, and the heat can be
redirected through a sophisticated
grid pattern that allows the heat to
be turned on and off.
"We have a huge amount of
flexibility in the distribution of the
heating pattern to the chest walls.
If the patient does have discomfort
in one part of the chest wall, we
can selectively reduce the heating
in that area," Myerson says.

"W;
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The clinical study
Each woman participating in the
study will receive four hyperthermia treatments. One area of her
chest wall, either the lateral or middle portion, will be heated and compared to the nonheated site.
Radiation will be applied to the
whole targeted area. Researchers
will look at long-term effects such as
tissue discoloration or scar tissue.
"The first group of patients will
receive four hyperthermia treatments," Myerson says. "If the late
effects in the heated portion of the
chest wall are not different than
those in the nonheated portion or if
the changes in the heated portion
are smaller than the benefits in
terms of attacking cancer cells,
then we will open the second 'arm'
of the study, and in the second arm
the patients will receive eight
hyperthermia treatments."
To be eligible for this study, a
woman must have had a tumor
that originally was larger than two
and one-half inches but either has
been removed or shrunk with
chemotherapy to an inch or less, or
she must have four or more lymph
nodes with cancer cells. Other criteria include a recurring cancer on
the chest wall that has not been
previously treated with radiation,
and a woman must be 18 years or

older. The study consists of two
"arms," and each arm will include
37 patients. To date, 11 women
have been accepted into the study.
In two previous studies, Myerson and coinvestigators looked at
the short-term effects of using
hyperthermia and radiation therapy
for women with high-risk breast
cancer and found that the patients
tolerated the treatments well.
These patients' tumors were larger
than the tumors of the women in
the current study, so these first
groups of women (72 total)
received four, six, or eight hyperthermia treatments. Results of
these previous studies showed that
the benefits of treatment with
hyperthermia outweighed any
adverse effects. This finding led to
the current five-year study.

Hyperthermia
Hyperthermia was first used in
the Radiation Oncology Center
at Mallinckrodt Institute in the late
1970s, where doctors found the
treatment to be effective in reducing large tumors. Treatments of 30
minutes to 60 minutes duration had
a palpable benefit in decreasing the
tumors and killing cancer cells,
according to Eduardo Moros, PhD,
a physicist in the Department of
Radiation Oncology.

THIS IMPORTANT
RESEARCH IS SUPPORTED BY TH ESE
NIH/NC1 GRANTS.

"Simultaneous thermoradiotherapi
breast earcino
Principal Investigator
Robert Myerson.
PhD, MD, professor
of radiation one

for simultaneous
thermoradiotherapy"
Principal Investigator
Eduardo Moros,
PhD, associate professor of radiation
oncology

Carlos Perez, MD,
professor of radiation oncology

William Straube, MS,
instructor in radiation oncology

Eduardo Moros.
PhD, associate professor ofradiation
oncology

Eric Klein. MS. associate professor of
radiation oncology

Marie Taylor. MD,
instructor in radiation oncology

William Straube. MS.
instructor in radiation oncology
Joanne Mortimer,
MD, associate j
sor of medicine
David Mansur, MD,
assistant professor of
radiation oncology
Imran Zoberi, MD,
instructor in radiation oncology
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"During the early eighties,
hyperthermia became the new
weapon against cancer, and its use
became very widespread in the
radiation oncology community,"
Moros says.
.
Companies began
manufacturing
mm
devices
W*\y
specifically
Hr
for different
^H
V
applications
of hyperther'
mia. Radiation
oncologists
Eduardo Moros, PhD
started clinical trials, and
hyperthermia studies began under
the auspices of the Radiation Therapy Oncology Group, a multi-institutional cooperative organization
comprised of major research institutions in the United States and
Canada. But as more clinical studies were done, investigators discovered the benefits of hyperthermia
were not as good as those reported
in earlier findings. Researchers
questioned the disparity and in the
late 1980s began to reassess the
treatment.
They concluded that "it was
more difficult to heat tumors than
was originally expected," says
Moros. Only tumors less than three
centimeters were responding positively to hyperthermia. According
to Moros, researchers looked at

v^~

12

thermometry and the devices used
for delivering the treatment, and
changes were made in 1991. "Basically we scratched ninety percent
of the clinical equipment we had
and started over," he says.

Simultaneous
therapy
Around 1993, researchers and
clinicians decided that one
avenue to pursue was delivering
the hyperthermia and radiation at
the same time. In the past, some
patients with recurring breast cancer appeared to need more radiation than their bodies could safely
handle. "There is, of course, a limit
to the amount of radiation that can
be given to a patient or to a particular volume of tissue," Moros
explains.
But radiation dosage could be
maximized when used in tandem
with hyperthermia, and this synergism resulted in more cancer cells
being killed with each dose and
with little or no adverse effects.
According to Moros, the most common adverse effect of hyperthermia is blistering; burns rarely
occur.
Myerson realizes that 41°C
sounds like a high temperature, but
he reminds patients that hot tubs
are usually set at the same temperature. Also the patient's whole
body does not reach 41°C, just a
small area of skin about six inches
wide on the chest wall. "Most
patients tolerate the heat treatment
extremely well," he says.

MALLINCKRODT INSTITUTE OF RADIOLOGY

Research and development
In the Department of Radiation
Oncology, the ultrasound-delivered heat is given before and after
the radiation therapy, with patients
receiving both heat and radiation
treatments in the same room from
two separate pieces of equipment.
Moros is principal investigator of a
National Institutes of Health/
National Cancer Institute grant to
design a new ultrasound system.
He and Petr Novak, a research
associate, are designing portable
equipment that can be integrated
into the stationary radiation-delivery system. A lightweight model of
the equipment is about the size of a
laptop computer. The new equipment uses ultrasonic rays, which
are aimed at two mirrors that move
and direct the rays to the targeted
area. By bouncing the rays off the
moving mirrors, a large area can be
covered without having to move
the ultrasound source. Current
equipment operates at frequencies
of 1 MHz and 3.5 MHz, allows penetration at 8 centimeters or 3 centimeters respectively, and has no
mechanism adjustments to the penetration area . The new equipment
will operate at 1 MHz and
5 MHz and will allow for adjustments by having one ray firing at
5 MHz and one at 1 MHz.
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"The new system is like
mixing two colors to get a color in
between," Moros explains.
He and Novak plan to have
the new device completed within
the next two years, Moros says,
adding that commercial equipment
has already been modified to
achieve some of the elements
available in the new equipment.
Three-dimensional capabilities,
portability, and ability to deliver
heat simultaneously are all elements that previously have not
been available in one machine.
"Hyperthermia in conjunction
with radiation therapy was always
considered a last resort for recurring breast cancer," Moros says.
"But with recent advances in
technology, patients are now
being treated with simultaneous
therapy before receiving standard
radiation." EH
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Editor's note: If you are
interested in participating in the
Department of Radiation Oncology's
simultaneous hyperthermia
and radiotherapy study, call
314-454-7226 for more information.

Linear Arrays System). External beam
radiotherapy and ultrasound hyperthermia
can be delivered simultaneously to a
superficial target. The applicator's dimensions (especially the height, -2.6 cm) and
construction materials were selected to
assure acceptable attenuation of the
photon/electron beam.
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A VISION FOR THE FUTURE
^^

Today, the field of radiology is focused on using
_•

sophisticated imaging tools—positron emission tomogra-

phy (PET), computed tomography (CT), magnetic resonance
imaging (MRI), ultrasound, and even digital radiography—to detect
anatomic changes that indicate disease. In a case of suspected breast
cancer, for example, the radiologist draws from an arsenal of diagnostic imaging
tools to determine whether the mass is malignant, based on its density, margins,
bulk, and blood flow.

But in David Piwnica-Worms' vision of the postgenomic future, molecular imaging will change this
picture, shifting the emphasis away from anatomy to specific receptors, enzymes, or genes and how
they are expressed. To evaluate that breast mass, the physician might ask these kinds of questions:
Is there a mutant P53 transcription factor present? Is a transporter such as MDR1 P-glycoprotein
expressed on its surface? And what do those things reveal about its characteristics?

BY CANDACE O'CONNOR

"As researchers, we can envision that twenty-five or thirty years
from now medical practice will
occur mainly at a genetic and molecular level, where there are certain
biochemical signs that will be
treated systemically with highly
targeted, specific drugs," says
Piwnica-Worms, professor of radiology and of molecular biology and
pharmacology. "That means a
large swath of anatomic disease
may no longer exist because it is
treated as a molecular, biochemical
abnormality long before there is
any anatomic change."
Piwnica-Worms and Mallinckrodt Institute of Radiology (MIR)
have just taken a giant step toward
that future by receiving a major
five-year, $10.5 million grant from
the National Cancer Institute (NCI)
to establish a molecular imaging
center at Washington University.
Its goal is to bring together Washington University investigators
from different disciplines to apply
molecular imaging approaches to
various cancer-related questions.
The grant places MIR and
Washington University in elite company, as one of only five medical
facilities in the United States
awarded these P50 center grants to
date. Of these five, MIR is the only
one to have three major elements:
■ the Molecular Imaging Center
(MIC), directed by David
Piwnica-Worms, MD, PhD
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■ a small-animal imaging resource,
headed by Joseph Ackerman,
PhD, professor of chemistry and
of radiology
■ an isotope research resource,
under Michael Welch, PhD, professor of radiology and of chemistry.
The earlier phase of the grant
application process also attests to
MIR's reputation. When the NCI
announced this new program in
1999, Piwnica-Worms applied for
one of the nine initial P20 planning
grants to lay the groundwork for
the MIC. The resulting three-year,
$1.2 million grant allowed him and
his colleagues to begin several pilot
projects. One involved Jeffrey Milbrandt, MD, PhD, of the Department of Pathology, who was
looking at patterns of gene expression in prostate cancer models;
another had Paul Allen, PhD, also
of the Department of Pathology,
studying T-cell trafficking in vivo
in a tumor ablation model. This
year, they were among the first
group of centers to convert from a
planning grant to a full center
grant.
Today, the MIC is composed of
several parts. There are four major
RO-1 research projects—running
the gamut from basic cell biology
to translational research to a
molecular imaging clinical trial in
humans—all designed to be
multidisciplinary, with molecular
biologists, biochemists, and imaging scientists working together.
There are also four multidisciplinary pilot projects, which may
eventually develop into RO-1 pro
jects. Then there is the education
and training piece, in which lee
tures and seminars train people in
molecular imaging techniques

u

And supporting all of this are
three core segments:
■ Molecular probe, which provides
molecular biology reagents
tooled to apply to molecular
imaging applications. Codirected
by Kathryn Luker, PhD, research
instructor in radiology.
■ Chemistry, which provides
chemistry expertise to deal with
specific reagents, contrast
agents, and radiopharmaceuticals. Codirected by Vijay
Sharma, PhD, assistant professor
of radiology.
■ Image analysis, which helps
researchers who have no imaging expertise to analyze their
images. Codirected by Richard
Laforest, PhD, assistant professor of radiology.
Altogether, the MIC involves
some 45 to 50 researchers from
areas as diverse as pathology,
immunology, radiation oncology,
radiology, molecular biology, pharmacology, cell biology, and chemistry. And word of the Center is
spreading quickly. "There has been
a ground swell of interest from colleagues in a wide variety of departments," says Piwnica-Worms,
"which shows the need for this
approach and the recognition that
molecular imaging represents an
exciting, new paradigm shift."
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David Piwnita-Worms, MD, PhD

THE GROWTH OF
MOLECULAR IMAGING
The impetus behind the MIC
came from Piwnica-Worms, who
has been interested for some time
in exploring a multidisciplinary
approach to imaging questions.
Piwnica-Worms, whose doctoral
work was in cell physiology, completed a diagnostic radiology residency at Brigham and Women's
Hospital in Boston, where his
group developed diagnostic radiopharmaceuticals used in animal
studies. In one study, a contrast
agent was injected into a lab rat,
and images were taken as the agent
entered the animal's heart.
"But no one was asking where
the radiopharmaceuticals went in
the heart cell or what the biochemical pathways of localization were,"
he says. "The chairman of the radiology department supported my

interest in these areas, using new
agents. These radiopharmaceuticals ended up having some very
interesting biochemical mechanisms, which led me to look at
imaging problems from a biochemical perspective."
Piwnica-Worms came to MIR in
1994 and set up his own lab along
these same lines, with chemists,
molecular biologists, and imaging
scientists involved. At times, that
cross-pollination has created a
remarkable synergy. "Researchers
have gained insight into a biological problem because of the chemistry. Or they have planned the
chemistry because they have biology in mind while addressing
certain questions or directing the
synthesis," he says.
Meanwhile, molecular imaging
took off as a field around 1998,
when groups began describing the
new research approach as "characterizing and measuring biological
processes in animals and humans
at the cellular and molecular level,
using remote imaging detectors."
So many researchers have since
become interested in the field that
they have formed the Society for
Molecular Imaging, which has
already established links with older
groups such as the American
Association of Cancer Research.
But this approach,-though new,
is actually a way to broaden the
scope of an existing field: nuclear
medicine. For instance, a critical
nuclear medicine tool—fluoro-2deoxy-D-glucose (FDG) PET imaging—already involves the
molecular probing of a transporter
and a specific enzyme. Another
important tool, octreoscan receptor imaging, has long used a
peptide-based radiopharmaceutical
to study the expression of somato
.tin receptors type 2 (SSR-2)
in tumors.

And some of the
taking part in the Molecular Imaging Center have been working in
nuclear medicine for some time.
Michael Welch, who also codirects
MIR's Division of Radiological Sciences, was one of the first
researchers to apply modern
organic chemistry to the preparation of radiopharmaceuticals used
in medical imaging and has long
developed radiopharmaceuticals
that target enzymes and receptors.
For the past decade, PiwnicaWorms himself has been doing
functional imaging of the multidrug
resistance (MDR1J P-glycoprotein
transporter, expressed in many
cancers.
\.
"But for a major cohort of the
investigators, the MIC represents
an entirely new source of funding
and collaboration that would not
have existed except for this initiative," says Piwnica-Worms. "And
now that the MIC is here, a dozen
other relationships are forming
because of the infrastructure that
has been built and the expertise
that has been developed. So, in a
major way, the Molecular Imaging
Center has generated brand-new
collaborations, new types of
research."
A PARADIGM SHIFT
While it can still be used to
make diagnoses, assist in therapeutic planning, and predict prognosis,
molecular imaging represents a
number of distinct differences over
traditional imaging. Conventional
radiology aligns researchers and
even clinicians by their expertise in
different kinds of technology, such
as MRI or CT, but molecular imaging does not. Instead, it addresses
basic biological questions and
matches those questions to the
tools that best answer them.

\KT
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It also ailows^esearchers to
look at molecular events, but not
just in a tissue■culturexir as an isolated specimen under amicroscope. Rather, molecularimaging
lets scientists study biochemical
abnormalities in living organisms,
such as transgenic or genet-deleted
mice, at the cellular and molecular
level. To do this, the scientists
need imaging tools-^PET/SPECT or
micro-PET) as well as^e rigor of
molecular cell biology anchsiochemistry to vahdtffe their riiuriqgs.
o molecular imaging takes
the power of molecular biology and
marries it with the technologies of
the imaging department and begins
to look at biochemistry and physiology in a new way," says PiwnicaWorms.
yS
Another change is the shift
away from the slow-moving
process of developing radiopharmaceuticals that target a specific
tumor receptor. Molecular imaging
also uses "reporter genes"—
enzymes, added to the cell, which
are imageable reporters of underlying gene regulation. In a matter
of months, these reporter genes
can be added to an entire cellular
system and then used to study
many different biological questions
in vivo.
And this approach also has the
potential to move medicine away
from what Piwnica-Worms calls
"group therapy," or the idea of
"treating all patients the same with
the same drug and the same dose
nd hoping that twenty-five percent
f them respond," he says. In the
uture, physicians will be able to
.ailor therapy to the individual.
"Clinicians will be able to get a
molecular signature of each person
and then manage therapy, diagnose, and guide patient management on an individual basis."
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THE MIC'S FUTURE
Along with his hopes for
molecular imaging, PiwnicaWorms also has goals for the
MIC. Currently, the imaging
center is a collaborative
research network, not a
physical space. Eventually,
he would like to see it
become a large, centralized
laboratory facility where
researchers could work near
Imaging protein-protein interactions in vivo using
collaborators in other departmicroPET and reporter genes. The binding of one protein
ments. He would also like to see
to another protein within cells regulates how cells divide,
the MIC expand the scope of its
sends signals from the cell exterior to the cell interior, and
mquiry beyond cancer to areas
mediates when and how cells move, grow, and die. Molesilsh as infectious, cardiovascucular
imaging of these protein-protein interactions in vivo
lar, ahdrieurologic disease.
will
provide
a broad-based tool for researchers to integrate
For rtsw, Piwnica-Worms is
existing knowledge of protein interactions within the compleased with^fche progress made,
and he remains intrigued by the
plex physiological context of living animals. Here, a tumor
concept of molecularsmaging,
suppressor protein known as p53 and a viral transforming
including its aesthetic qttahties.
protein known as large T antigen (TAg), two intereacting
"For seasoned investigators^
proteins known to be involved in turning a normal cell into
he says, "science is like art.
cancer, are each fused to different portions of a transcripThere is beauty and creativity in I tion factor. Both portions of the transcription factor are
a well-conceived experiment or
required to activate a PET reporter gene known as HSV1
a beautifully done series of
thymidine kinase, but only one portion can bind on its own
studies."
to specific DNA sequences that regulate activation of the
One of the recent research
reporter. However, when pS3 and TAg proteins interact,
papers from Piwnica-Worms' lab
the second factor is now properly assembled, thereby
contains an image of a mouse
switching on the reporter gene. The activated reporter
with two tiny tumors in its axilla.
Proteins on these tumors must
can be detected by microPET imaging of living mice
interact to turn on a PET reporter
using the positron-emitting radiopharmaceutical
gene, which makes it possible for
18F-FHBG. (Left) Photograph of the anterior thorax
scientists to image them. "These
of a mouse with axillary xenograft tumors containproteins interact and dance," says
ing non-interacting proteins (small arrow) and
Piwnica-Worms, "so that we are
interacting p53-TAg proteins (large arrow).
able to look at them from outside
(Right) Coronal microPET image of the same
the body. That is really exciting for
mouse showing accumulation of 18F-FHBG only
me. I find great satisfaction in the
in the tumor expressing the interacting
rigor, the vision, and seeing it all
p53-TAg proteins (large arrow). Asterisk
happen."
denotes radiotracer in the gallbladder.
Intestinal activity from normal hepatobiliary clearance of the radiotracer is
observed in the lower portion of
the image.
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RESEARCH PROJECTS
The Molecular/Imaging Center includes four major RO-1 grants, which
are directed by researchers from a wide range of disciplines. "The
Cen :er provides a vehicle for researchers with diverse expertise to
6gether to design novel, multidisciplinary strategies that answer
important biological questions," says Jeffrey Milbrandt, MD, PhD,
fessor of pathology and medicine.
He and Gary Luker, MD, instructor in radiology, are developing a system to detect the activity of a specific pathway in living animals.
Eventually, this may let physicians monitor the growth of tumor cells
in vivo, along with the human response to chemotherapeutic agents.
Molecular imaging is exciting, says Milbrandt, because it enables him
to track the activity of a single gene in order to determine how tumor
progression is affected by the integrated biology of a living system.
"This will hopefully enable me to understand how molecular
changes result in malignant transformation," he says.
Bioluminescence of tumor xenografts in
a living mouse: Firefly luciferase, the
same gene that makes fireflies glow,
has been transduced into human HeLa
cervical carcinoma cells and tumors
grown in an immunocompromised
mouse. Substrate for the luciferase
enzyme was injected into the mouse
causing only the four transduced tumors
to glow. The images are obtained in a
special light-tight box with a sensitive
CCD camera. Regions-of-interest can be
demarcated on the images to quantify
the areas of gene expression.

In his project, Paul Allen, MD, professor of pathology, is continuing
his pilot project research into T-cell trafficking in an immunotherapy
tumor ablation model. And Lee Ratner, MD, PhD, professor of medicine and of molecular microbiology, is focusing on two human
pathogens associated with tumors-human immunodeficiency
virus (HIV) and human T-cell lymphoma/leukemia virus (HTLV)with a goal of imaging virus-infected cells in vivo. "Our research
group's interest is in examining the efficacy of antiviral therapies in
many different tissues of infected individuals," he says.
Finally, David Piwnica-Worms, MD, PhD, is collaborating with medical oncologist Ramaswamy Govindan, MD, instructor in medicine;
radiologist Farrokh Dehdashti, MD, associate professor of radiology;
and chemist Michael Welch, PhD, professor of radiology and of
chemistry, in a clinical trial of molecular imaging. Patients with
advanced, small-cell lung cancer will have a technetium-94m-sestamibi scan shortly before therapy, then the researchers will observe
the patients over time to see how the imaging predicts their outcome
and the occurrence of multidrug resistance (MDR), a much-feared cause
of chemotherapy failure in several forms of cancer.
"Our goal is to know early on that a patient is likely to become multidrug
resistant," says Piwnica-Worms. "With this information, a physician
could alter the patient's therapy; and, since patients who present with
MDR tend to have a more aggressive course of disease, the physician
could also have some prognostic information." EM

Editor's note: A listing of key faculty for the Molecular Imaging Center
was announced in the "Spot News" section of the fall/winter 2001
Focal Spot magazine.
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RADIOLOGY AT THE Winter

Olympics

The nineteenth Winter
Olympics had all the ingredients of a sports fan's dream:
drama (accusations of rules
violations, unfair judging,
and drug use), memorable performances (from dark-horse Sarah
Hughes' spectacular figure-skating
performance to Jim Shea's bittersweet victory in the skeleton
event), wins (more gold medals
won by the United States in 2002
than in any other Winter
Olympics), and a rousing flourish
of Americana in the closing ceremony (including singers Bon Jovi,
Willie Nelson, and Gloria Estefan).
William Middleton, MD, professor of radiology, was among those
fans attending the 2002 Winter
Olympics in Salt Lake City, Utah,
in February. He was not there as a
spectator but as an official member
of the Olympics medical team.
Nationally known for his expertise
in musculoskeletal ultrasound,
Middleton was one of eight radiologists from the United States' top
medical centers invited to staff the
Olympic Polyclinic and provide
health care for the athletes,
coaches, and trainers.

"It was personally very gratifying to be invited, but I was especially pleased that the organizing
committee responsible for the
Polyclinic recognized the contribution ultrasound could make to
these athletes," says Middleton.
For an athlete, a quick diagnosis of an injury could mean the
difference between returning to
competition or being forced to
withdraw. The Polyclinic staff diagnosed and treated common, sportsrelated injuries as well as more
chronic injuries for the 2,500-plus
athletes representing 77 countries.
Cases ranged from a German bobsledder's torn plantar fascia (the
fibrous sheet of tissue on the sole
of the foot) to a Canadian skier's
patellar tendonitis to a Caribbean
bobsledder's scrapes and cuts.
Middleton also saw cases of existing medical problems such as
kidney stones and gallstones.

"For the injured athlete, radiology was the nerve center of the
Polyclinic. Everyone, including
the athlete, the trainer, the
doctor, and sometimes teammates,
congregated in our reading room
to see how serious the injury was,"
says Middleton. "The athletes'
decision whether or not to return
to competition frequently hinged
on the results of their scans."
The clinic was open from 8 in
the morning until 11 in the evening
each day and was always staffed by
one or two radiologists. The facility
was equipped with digital healthimaging equipment, including a
mobile magnetic resonance scanner, an ultrasound machine, and
X-ray equipment. Patients who
needed computed tomography
scans were sent to nearby
University of Utah Health
Sciences Center.

Hockey player with shoulder pain. The ultrasound
shows a defect (cursors) in the surface of the humeral
head typical of a compression fracture (called a Hill
Sachs deformity) that occurs with shoulder dislocaDownhill skier with right knee pain. The ultrasound

tion. This could not be seen on Xrays.

shows thickening and distortion of the right (RT)
patellar tendon (cursors) typical of patellar tendonitis.
The normal left (LT) patellar tendon is seen for
comparison.
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Above: From the ultrasound, Middleton could

OLYMPICS TRIVIA

determine that this member of the Canadian

■ The Olympics were held in St. Louis in 1904, occurring simultaneously with the
Louisiana Purchase Exhibition (or World's Fair). Boxing was added as an

ski team had patellar tendonitis.

Olympic sport during the 1904 games.

Middleton's tour of duty was
the last week of the Olympics. A
standard shift was eight hours, but
Middleton says he liked to extend
his shift to take full advantage of
the once-in-a-lifetime experience.
"In radiology we saw, on average,
one patient every thirty minutes,"
he says. "Performing and interpreting the scans was the easiest part.
Dealing with a new dictating system, new PACS system, new ordering system, and an unfamiliar
support staff was the tough part.
Getting the films and reports to the
athletes so they could take the
records to their hometown physicians was, perhaps, the most difficult part of all my medical
responsibilities."
This year was the first time
Middleton was involved in the
Olympics, and he says he would
enjoy being on the medical staff for
future games. The Winter Games
in Turin, Italy, are only four years
away. ES3

■ The flag flown at all Olympic games was introduced during the 1920 games in
Antwerp, Belgium. It contained 5 interlocked rings representing the five significant continents. At least one of the colors in the flag—blue, yellow, black, green,
and red—appears on the flag of every country in the world.
■ The first Winter Olympics were held in 1924.
■ An estimated 3.5 billion people worldwide watched the 2002 televised games.
■ There were more than 55,000 spectators in the Rice-Eccles Olympic Stadium
during the 2002 Winter Olympics closing ceremony.
■ 15,000 police troops and security volunteers made this year's games one of the
safest in Olympic history.
■ The United States won 34 medals (10 gold, 13 silver, 11 bronze) in the 2002
games. Germany was in first place with 35 medals; Norway was third with
24 medals; Russia and Canada tied for fourth place with 17 medals each.
■ Women's bobsled was introduced at the 2002 Winter Games. The U.S. team
won a gold medal, and Vonetta Flowers, the team's pusher, was the first black
athlete ever to win a gold medal in the Winter Games.
■ Freestyle skier Shannon Bahrke won the United States' first medal (a silver) the
first day of competition.
■ Snowboarder Chris Klug won a bronze medal in the parallel giant slalom—
just 19 months after undergoing a liver transplant.
■ This was Brian Shimer's fifth, and last, Winter Olympics competition. Shimer
won his first medal—a bronze medal in men's bobsled.
■ Jimmy Shea's father and grandfather were Olympic athletes. Shea won a gold
medal this year in skeleton.
■ At the opening ceremony, U.S. athletes carried the tattered American flag from
the World Trade Center.

a convenient, more private facility

by Vicki Kunkler

February 5 not only marked the grand opening of The Charles F. Knight Emergency and Trauma
Center but also the finalization of the Washington University Medical Center campus integration
project begun in 1996. The emergency facility, housed in the new southwest tower at 400 South
Kingshighway Boulevard, serves patients previously seen at three medical center emergency care
units: Barnes-Jewish Hospital (BJH) south, the Schukar unit, and BJH north.
The facility is divided into areas for urgent care, emergent care, trauma/critical care, and observation—each with its own waiting areas and nursing stations. The center has a convenient, patient/
visitor parking garage; a covered ambulance bay; a dedicated elevator for the roof-top helipad; a
work room for police, EMS personnel, and firefighters; and a state-of-the art radiology section. El

FOR THE RECORD
• More than 80,000 patients annually receive
emergency or trauma care at Washington
University Medical Center.
• The Emergency and Trauma Center was
built to exceed earthquake safety standards.

• BJH is the only St. Louis hospital to be accredited
by the American College of Surgeons as a Level I
Trauma Center.
Below left: Christine Peterson, NID, setond-year diagnostic radiology
resident, and David Rubin, MD, assistant professor of radiology and

• Biological or decontamination needs are
served by inside and outside decontamination units with separate septic systems.

chief of musculoskeletal radiology, are shown in the reading room.
Below middle: A spacious lobby — and friendly faces — welcome patients

• The new center covers 52,000 square feet
and has 61 beds.

to the Emergency and Trauma Center.

• The facility has computerized triage, tracking, order entry, and documentation systems.

Tincher, RT(R), in the control room for the new Volume Zoom CT scanner.

Below right: Christine Menias, MD, instructor in radiology, and Chris

• Washington University Medical Center has
the only academic emergency medicine
residency program in the St. Louis area.
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In this section, the names of employees who are full-time
faculty or staff or who have an appointment in the Department of Radiology or Department of Radiation Oncology
are highlighted in boldface type.

PROMOTIONS

NEW FACULTY

Walter Bosch, DSc, instructor in radiation oncology,
was promoted to research
assistant professor of radiation oncology, Physics Division, Department of
Radiation Oncology.

Bhargavi Patel, MD,
visiting instructor in radiology, Division of Diagnostic
Radiology, Department of
Radiology.

Clifford Chao, MD, assistant professor of radiation
oncology, was promoted to
associate professor of radiation oncology, Clinical Division, Department of
Radiation Oncology.
Robert Drzymala, PhD,
assistant professor of radiation oncology, was promoted
to associate professor of
radiation oncology, Physics
Division, Department of
Radiation Oncology.
William Straube, MS,
instructor in radiation oncology, was promoted to
research assistant professor
of radiation oncology,
Physics Division, Department of Radiation Oncology.

Alan Williams, MD,
instructor in radiology, neuroradiology section, Division
of Diagnostic Radiology,
Department of Radiology.

FIRST-YEAR
DIAGNOSTIC
RADIOLOGY
RESIDENT

GRANTS

Humberto Rosas, MD,
assistant in radiology,
received a medical degree
from Duke University School
of Medicine. He completed a
two-year surgery internship
at Barnes-Jewish Hospital,
St. Louis.

Carolyn Anderson, PhD,
associate professor of radiology and of molecular biology
and pharmacology, received
a $1.6 million grant from the
National Cancer Institute to
study "Radiopharmaceuticals based on cross-bridged
ligands." Anderson and
Edward Wong, PhD, University of New Hampshire, are
principal investigators for
the five-year grant. Mallinckrodt Institute coinvestigators

Senturia
Lecture
The Eighth Annual Hyman
R. Senturia Lecture was
presented on February 22.
Rosemary Stevens, PhD,
MPH, professor of history
and sociology of science at
the University of Pennsylvania, spoke on "The formal structure of specialization in
medicine." William Reinus, MD, associate professor of radiology and coordinator of the
Senturia Lecture, presented Stevens with a commemorative plaque.

MALLINCKRODT INSTITUTE OF RADIOLOC

.je Xiankai Sun, PhD,
research associate, and Mu
yang, MD, staff scientist.
Consultant is Michael
Ifelch, PhD, professor of
radiology and of chemistry
and codirector of the
Division of Radiological
Sciences.
Robert Gropler, MD, associate professor of radiology,
of medicine, and of biomedical engineering, as principal
investigator, received a
$1.5 million grant from the
National Institutes of Health
for "PET quantification of
ayocardial substrate metabolism." Coinvestigators are
?ilar Herrero, MS,
research scientist of
radiology; Gary Hoffman,
research associate; Terry
Sharp, technical supervisor;
Zulfia Kisrieva-Ware, MD,
PhD, data analyst; Matthew
Marison, research technician, Department of Internal
Medicine; Jun Young Kwon;
John Holloszy, MD, professor of medicine; Michael
Welch, PhD, professor of
radiology and of chemistry;
and Samuel Klein, MD, professor of medicine.
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Jacob Locke, MD, instructor in radiation oncology, as
principal investigator,
received a five-year National
Institutes of Health Mentored
Physician-Scientist Grant to
study "Indomethacin and P38
regulating AP-1 in heat
shock." Locke's mentors for
the $618,000 grant are
Joseph Roti Roti, PhD,
professor of radiation oncology and director of the Division of Radiation and Cancer
Biology, and David PiwnicaWorms, MD, PhD, professor
of radiology and of molecular
biology and pharmacology.
Dmitriy Yablonskiy, PhD,
assistant professor of radiology and professor of physics,
as principal investigator,
received a $1.4 million grant
from the National Institutes
of Health/National Institute
of Neurological Disorders
and Stroke to study "Brain
temperature control during
functional activation." Coinvestigators for the four-year
grant are Marcus Raichle,
MD, professor of radiology
and of neurology and neurobiology and codirector of the
Division of Radiological
Sciences; Joseph Ackerman, PhD, professor of
chemistry, of medicine,
and of radiology; Larry
Bretthorst, PhD, research
associate; and Charles
Hildebolt, DDS, PhD, associate professor of radiology
and adjunct associate professor of anthropology.

Jie Zheng, PhD, research
assistant professor in radiology, as principal investigator, received the Charles E.
Culpeper Biomedical Pilot
Initiative, a one-year grant
sponsored by the Rockefeller Brothers Fund, to
study "Identification of rupture-prone coronary artery
plaques with magnetic resonance imaging." Coinvestigators for the $25,000 grant are
Ruth Okamoto, PhD, Department of Mechanical Engineering; Haodong Xu, MD,
Department of Pathology;
Jeffrey Saffitz, MD, Department of Pathology; and
Robert Gropler, MD, associate professor of radiology,
of medicine, and of biomedical engineering.

APPOINTMENTS/
ELECTIONS
Carolyn Anderson, PhD,
associate professor of radiology and of molecular biology
and pharmacology, was
appointed to the Washington
University Medical Center's
Continuing Review Committee for the Human Studies
Committee.
Thomas Conturo, MD,
PhD, associate professor of
radiology and adjunct professor of physics and of
biomedical engineering, was
appointed as an ad-hoc referee of National Institutes
of Health/National Institute
of Mental Health grants for
Studies to Advance Autism
Research and Treatment
Program (STAART) Centers.
Maurizio Corbetta, MD,
associate professor of neurology and of radiology, was
appointed to the editorial
board of the journal Cortex.
Dione Farria, MD, MPH,
assistant professor of radiology, was appointed to the
American Cancer Society's
Reach to Recovery Advisory
Board, Heartland Division.

APPOINTMENTS/
ELECTIONS
Continued from page 25
Jacob Locke, MD, instructor in radiation oncology,
was appointed as the Department of Radiation Oncology
representative to the Washington University Disclosure
Review Committee.
Robert McKinstry, MD,
PhD, assistant professor of
radiology, was appointed to
the National Institutes of
Health Ad Hoc Study Section, Center for Scientific
Review, High End Instrumentation Program.
Eduardo Moros, PhD,
associate professor of
radiation oncology, was
appointed to a three-year
term as a grant reviewer for
the National Institutes of
Health Center for Scientific
Review, Radiation Study
Section.
Joel Perlmutter, MD, professor of neurology and of
radiology, was appointed by
the American Academy of
Neurology as the 2002 Topic
Chairman for Neuroimaging.
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William Powers, MD, professor of neurology and of
radiology, was appointed to
the Oversight Committee for
the National Institute of Neurological Disorders and
Stroke Multicenter Trial of
Neuroprotection in Parkinson Disease. He was
appointed to the editorial
board of The Journal of
Cerebral Blood Flow and
Metabolism.
Marcus Raichle, MD, professor of radiology and of
neurology and neurobiology
and codirector of the Division of Radiological Sciences, is chairman-elect of
the American Association for
the Advancement of Science
Section on Neuroscience.
Marilyn Siegel, MD, professor of radiology and of
pediatrics, was appointed
chairwoman of the Refresher
Course Committee, Pediatrics Subsection for the
102'"t Annual Meeting of the
American Roentgen Ray
Society, to be held April 28
through May 3 in Atlanta,
Georgia.

HONORS/
AWARDS
Jeffrey Bradley, MD,
instructor in radiation oncology, served as an instructor
for the 3D Practicum at the
American Society for
Therapeutic Radiology
and Oncology Meeting in
St. Petersburg, Florida.
Clifford Chao, MD, associate professor of radiation
oncology, was a panel member for Operations Research
Applied to Radiation Therapy, a National Institutes of
Health/National Science
Foundation Workshop held
in Washington, DC.
Eric Klein, MS, associate
professor of radiation oncology, was named course
director for the American
College of Medical Physicists
Radiation Oncology
Refresher Course, held in
Orlando, Florida.

Joel Perlmutter, MD, professor of neurology and of
radiology, was selected by
The Hereditary Disease
Foundation as a participant
in the Venezuela Huntington
Disease Research Project.
He was named the external
advisor for the Molecular
Genetics of Early Onset Torsion Dystonia Program,
directed by Xandra O.
Breakefield, PhD, of the Molecular Neurogenetics Unit at
Massachusetts General Hospital in Boston.
David Piwnica-Worms,
MD, PhD, professor of radiology and of molecular biology and pharmacology, was
named chairman of the
American Association for
Cancer Research Conference
on Molecular Imaging in
Cancer: Linking Biology,
Function and Clinical Applications In Vivo, held in
Orlando, Florida.

Anurag Singh, MD, assistant in radiation oncology,
was elected to a two-year
term on the Executive Board
of the Association of Residents in Radiation Oncology.

MALLINCKRODT INSTITUTE OF RADIOLOG

,ECTURES/
'RESENTATIONS
Jeffrey Bradley, MD,
instructor in radiation oncology, as invited speaker, presented "Biologically-targeted
therapy for lung carcinoma:
the impact of PET on GTV
and conformal radiotherapy
planning" at the Functional
Imaging Symposium, Radiation Therapy Oncology
Group Meeting, Tampa,
Florida, January 31. As
invited speaker, he presented "Design of cooperative trials in North America"
at the 2002 Mid-Winter Educational Symposium of the
Society of Nuclear Medicine,
Scottsdale, Arizona, February 9 and 10.
Clifford Chao, MD, associate professor of radiation
oncology, spoke on "Tumor
hypoxia: from molecular signal transduction to functional imaging-guided
therapy" at Grand Rounds,
The University of Texas MD
Anderson Cancer Center,
Houston, Texas, January 23.
He presented "Clinical indications for IMRT;" "Planning
IMRT treatments: clinical
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input;" "Clinical consequences of IMRT;" and
"RTOG protocols for IMRT"
at the Medical Technology
Management Institute, Las
Vegas, Nevada, February 1
and 2. Chao presented
"Intensity-modulated radiation therapy (IMRT): new
treatment trends in oncology" at the Florida Hospital
Cancer Institute, Orlando,
Florida, February 21 and 22.

Steven Crawford, MD,
clinical fellow, presented
"Validation of an angiographic method for estimating flow to distal tissue
beds" at the 27th Annual Scientific Meeting of the Society
of Cardiovascular and Interventional Radiology, Baltimore, Maryland, April 7.

Colin Derdeyn, MD, associate professor of radiology,
as keynote lecturer, presented "Pathophysiology of
acute and chronic cerebrovascular disease" at the
2'"1 Annual International
Meeting of CT/MR Brain
Perfusion, San Francisco,
California, March 29.

Maurizio Corbetta, MD,
associate professor of neurology and of radiology, presented "Goal-directed and
stimulus-driven attention in
the human brain" at the Psychology Colloquium, University of Pittsburgh,
Pennsylvania, March 16.

Biello
Lecture
On March 11, Steven
Larson, MD, chief of
nuclear medicine
service at Memorial
Sloan-Kettering Cancer Center in New York City, presented The Sixteenth Annual
Daniel R. Biello Memorial Lecture, "Measuring tumor response with PET." Shown
with Dr. Larson (right) is Barry Siegel, MD, professor of radiology and of medicine and
director of the Division of Nuclear Medicine, and coordinator of the Biello Lecture.
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LECTURES/
PRESENTATIONS
Continued from page 27
Louis Gilula, MD, professor of radiology and of
surgery, spoke on "Vertebroplasty and metastatic disease" at Missouri Baptist
Hospital, St. Louis, Missouri,
January 17. He presented
"Imaging of distal radius
fractures" at the Wrist Workshop, sponsored by the Hand
Therapists and Trainers
Association, St. Louis, Missouri, March 5. Gilula spoke
on "Introduction to vertebroplasty," "Lumbar and sacral
nerve blocks," and "Discography-lumbar" at the 25"'
Annual Winter Skeletal Symposium sponsored by the
University of Pennsylvania,
Lake Louise, Alberta,
Canada, March 11-15. He
presented "Introduction to
vertebroplasty," "Technical
aspects of vertebroplasty,"
and "Problems in vertebroplasty and how to handle
them" at Orthopedic Radiology 2002, sponsored by the
Radiology Department of
Brigham and Women's Hospital, Boston, Massachusetts,
March 24-26.

Jay Heiken, MD, professor
of radiology, chief of abdominal radiology, and cochief of
body computed tomography,
presented "A practical
approach to small bowel
obstruction" at Twentieth
Annual Practical Radiology
at Whistler, sponsored by the
University of British Columbia, Whistler, British Columbia, Canada, February 3-8.
Anil Khosla, MD, instructor
in radiology, as invited
speaker, presented "CNS
manifestations of systemic
cancer;" "Extramedullary
cysts of spinal canal," "Diffusion weighted imaging-CNS
applications," and "Carotid
and vertebral artery dissection" at INDO-US Imaging
2001, Nizam's Institute of
Medical Sciences, Hyderabad, India, December 22
and 23. As invited speaker,
he presented "CNS manifestations of systemic cancer,"
"Diffusion weighted imaging
in CNS," "Extramedullary

cysts of spinal canal," and
"Spinal intervention procedures" at INDO-US Imaging
2001, Bhartiya Vidyapeeth
Deemed University, Pune,
India, December 25 and 26.
Khosla spoke on "CNS manifestations of systemic cancer" and "CNS applications
of diffusion imaging" at Neurology Update, organized by
the Department of Neurosurgery and the Department
of Radiology, Khoula Hospital, Muscat, Sultanate of
Oman, December 27.
Eric Klein, MS, associate
professor of radiation oncology, spoke on "Clinical IMRT
at Mallinckrodt Institute;"
"Technology assessment of
MLC, EDW, and IMRT;" and
"Heterogeneity corrections
and lung prescriptions" at
Stony Brook University Hospital, State University of
New York, Stony Brook,
New York, March 6. He presented "Heterogeneity corrections and lung
prescriptions in radiation
oncology" at the Florida
American Association of
Physicists in Medicine Meeting, Orlando, Florida, March
15. Klein presented "Accep-

tance, testing, and commissioning of Linacs;" "Facility
shielding, design, and general radiation safety;" and
"Special procedures: total
body irradiation, stereotac
radiosurgery, IMRT" at the
American College of Medic;,
Physicists Radiation Oncology Refresher Course,
Orlando, Florida, March 24
and 25.
Jason Lewis, PhD,
research instructor in radiology, presented "Radiopharmaceuticals: diagnostic and
therapeutic applications" at
Berlex Biosciences, San
Francisco, California,
December 11.
Elizabeth McFarland, MD,
associate professor of radiology, presented "CT colonography" at Internal Medicine
Grand Rounds, Washington
University School of Medicine, St. Louis, Missouri,
March 14.
Jeff Michalski, MD, assistant professor of radiation
oncology and director of the
Clinical Division, presented
"History and evolution of
external beam techniques.
RTOG 9406;" "3-D conformal
radiation therapy for
prostate cancer;" "3-D conformal radiation therapy for
prostate cancer: techniques;"
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nd "Prevention and management of radiation therapy
Complications" at the
ikuna-o-ka-la Radiation
cology Conference,
hala Coast, Hawaii, FebruM 12-15. He spoke on
decent advances in the
nanagement of prostate canfcer: advances in radiotherapy: brachytherapy and
External beam" at the International Center for
Advanced Medical Education, St. Louis, Missouri,
itarch 8.
Jeff Miller, research assisnt, spoke on "Temporal
evolution of brain injury in
erm newborns characterized by diffusion tensor
imaging" at the Annual Meeting of American Association
of Neurological Surgery Section on Pediatric Neurosurgery, New York City, New
York, December 1.
Carlos Perez, MD, professor of radiation oncology
and chairman of the Department of Radiation Oncology,
presented "Radiation therapy in postradical prostatectomy rising PSA" to the
greater St. Louis Society of

FOCAL SPOT, SPRING 2002

Radiologists, St. Louis, Missouri, February 19. He
spoke on "Cytoprotective
agents in combined modality
therapy in head and neck
cancer" and "Advances in
radiation oncology" at the 4th
Annual Palm Beach Cancer
Symposium, Delray Beach,
Florida, March 22 and 23.

Nuclear Medicine, Hawaii
Chapter, Honolulu, Hawaii,
February 16 and 17. Siegel
presented "FDG PET: artifacts and variants" at the
2002 Mid-Winter Educational Symposium of the
Society of Nuclear Medicine, Scottsdale, Arizona,
February 9 and 10.

Mehdi Poustchi-Amin,
MD, clinical fellow, presented the scientific exhibit
"Principles, applications and
protocols of the practical
MRI of the body" at the 13th
Annual Meeting of the American Society of Emergency
Radiology, Orlando, Florida,
March 16-20.

Marilyn Siegel, MD,
professor of radiology and
of pediatrics, presented
"Ultrasonography of neonatal retroperitoneal masses,"
"Neonatal intracranial hemorrhage and ischemic brain
injury," "Congenital brain
anomalies," and "Ultrasonography of the neonatal liver"
at the Snowmass 2002 Clinical Ultrasound Meeting,
Snowmass, Colorado,
March 4-6.

Barry Siegel, MD, professor of radiology and of medicine and director of the
Division of Nuclear Medicine, as visiting professor,
spoke on "Oncologic FDGPET: artifacts, variants, and
benign lesions simulating
cancer" and "Current status
of PET in clinical practice"
at Brown University School
of Medicine and Rhode
Island Hospital, Providence,
Rhode Island, January 7. He
presented "FDG-PET: artifacts and variants" and
"Applications of PET in
oncology" at the 19th Annual
Conference of the Society of

Yuan-Chuan Tai, PhD,
assistant professor of radiology, spoke on "MicroPETpositron emission tomography in molecular imaging" at
the American Association for
Cancer Research Special
Conference in Cancer
Research: Molecular Imaging
in Cancer, Orlando, Florida,
January 26.

Jerold Wallis, MD, associate professor of radiology,
presented "Current status of
nuclear medicine interconnectivity" at the High Country Nuclear Medicine
Conference, Vail, Colorado,
March 1-6.
Franz Wippold, MD, associate professor of radiology
and chief of neuroradiology,
as visiting professor, spoke
on "Anatomy of the temporal
bone" and "Lesions of the
cerebellopontine angle" at
Michigan State University,
East Lansing, Michigan,
March 11 and 12.

SYMPOSIA
In this section ofFYI, only
those faculty and staff
who have Department of
Radiology or Department
of Radiation Oncology
appointments are listed.

THE AMERICAN ASSOCIATION OF NEUROLOGICAL
SURGEONS/CONGRESS
OF NEUROLOGICAL
SURGEONS SECTION
ON CEREBROVASCULAR
SURGERY AND THE
AMERICAN SOCIETY
OF INTERVENTIONS
AND THERAPEUTIC
NEURORADIOLOGY
The Fifth Joint Annual
Meeting
Dallas, Texas
February 3-6, 2002
DeWitte Cross, MD, member, Abstract Committee;
moderator, Oral Presentations 11-20.
Colin Dereyn, MD, corrector, Special Course: Technical and Pharmalogic
Considerations in Acute
Stroke Therapy and Intracranial Angioplasty/Stenting.
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ORAL PRESENTATIONS
Colin Derdeyn, MD;
Christopher Moran, MD;
DeWitte Cross, MD; David
Jeck, MD; Thomas Pilgram, PhD; Keith Rich,
MD; Robert Grubb, MD,
"Procedural thrombus and
postprocedural ischemic
events after treatment of
intracranial aneurysms with
GDC."
Colin Derdeyn, MD; David
Jeck, MD; Christopher
Moran, MD; DeWitte
Cross, MD; Keith Rich,
MD; Robert Grubb, MD,
"Long-term outcome after
angioplasty for symptomatic
carotid stenosis."
SPECIAL COURSE
Intracranial Atherosclerotic
Disease and Revascularization

Colin Derdeyn, MD, "BC-IC
bypass study results, controversies, new trials."
POSTER PRESENTATION
David Jeck, MD; DeWitte
Cross, MD; Colin
Derdeyn, MD; Christopher
Moran, MD, "Carotid stenting for treatment of carotid
dissection."

INTERNATIONAL
SOCIETY FOR MAGNETIC
RESONANCE IN MEDICINE
Diffusion MRI: Biophysical
Issues (What Can We
Measure?) Workshop
Saint-Malo, France
March 10-12, 2002
Thomas Conturo, MD,
PhD, chairman, "Diffusion
and Pathophysiology" scientific session.
ORAL PRESENTATIONS
Nicolas Lori, graduate
research assistant in radiology; Erbil Akbudak, PhD;
Joshua Shimony, MD,
PhD; Abraham Snyder,
PhD, MD; Thomas Conturo, MD, PhD, "Identifying
the white matter pathways
involved in lesions and MRI
contrast patterns using diffusion tensor tracking."
Nicolas Lori, graduate
research assistant in radiology; Thomas Conturo, MD,
PhD, "Diffusion time assignment and q-space formalism
for finite-duration diffusionencoding gradients: simulation of 3D random walks."
Jeffrey Neil, MD, PhD,
"Diffusion anistropy in the
developing human brain."

POSTER PRESENTATION
Joshua Shimony, MD,
PhD; Abraham Snyder,
PhD, MD; Nicolas Lori,
graduate research assistant
in radiology; Thomas Conturo, MD, PhD, "Automated
clustering of diffusion tensor
track data into neuronal
pathways."

SOCIETY OF COMPUTED
BODY TOMOGRAPHY
AND MAGNETIC
RESONANCE
Twenty-fifth Annual Course
Charleston, South Carolina
March 18-22, 2002
Stuart Sagel, MD, moderator, Thoracic Imaging.
Marilyn Siegel, MD, moderator, Pediatric Imaging.
CUM LAUDE SCIENTIFIC PRESENTATION AWARDS
Kyongtae Bae, MD, PhD;
Jay Heiken, MD; Huy
Tran, MD, "Uniform vascular contrast enhancement
and reduced contrast volume
achieved by multiphasic
injection method: clinical
validation."
Sanjeev Bhalla, MD; Eliz
beth McFarland, MD;
Ronan McDermott, MD;
Christine Menias, MD;
Amy Hara, MD; Adolf
Huette, MD; Thomas
Pilgram, PhD, "Prospective
MDCT study of CT
colonography compared
to colonoscopy: diagnostic
performance of experienced
and recently trained
readers."
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Elizabeth McFarland, MD;
Kirk Smith, senior research
; engineer; Jeffrey Marsh,
MD; Thomas Pilgram,
PhD, "MR evaluation of sta; ic and dynamic relationships of the velopharynx
during speech in controls
and cleft palate pediatric
subjects."

AORKSHOPI
^F'ongtae Bae, MD, PhD,
iging coronary arteries
w^i multislice CT."
F/iartSagel, MD, "CT of
*«ascular mediastinal
:11 ons."

WORKSHOP II
Stuart Sagel, MD, "CT of
Ithe pleura."

WORKSHOP
IV
Wi
Ja Heiken, MD, "Liver
Jay
lesion
Les
characterization with
n and MR: a practical
CT
approach."
ap
INTERACTIVE CASE SESSION
Jay Heiken, MD, "Body
imaging."

XUS SESSION:
UICREATIC-BILIARY
ay Heiken, MD, "Imaging
ncreatic carcinoma with
L and MR."

PEDIATRIC IMAGING
Marilyn Siegel, MD, "CT of
pediatric renal masses,"
"CT/MRI of pediatric liver."

THORACIC IMAGING
Stuart Sagel, MD, "CT of
the pericardium."
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IN MEMORIAM
It is with profound sadness that we report the
death of Juan M. Taveras,
MD, the third director of
Mallinckrodt Institute of
Radiology. Taveras, 82, died
in his native Dominican
Republic on March 28 from
leukemia.
Taveras was one of the
world's leading neuroradiologists, and under his leadership the Institute became a
major center for neuroradiological research and clinical
studies. During his directorship, the Institute underwent
a tremendous expansion in
organization and the physical
plant, including further organization of the subspecialty
system (begun by Hugh Wilson, MD, second director of
MIR), funding for the addition of four new laboratories
and five shell floors, and construction of Scarpellino
Auditorium.
Taveras came to MIR in 1964
from the Neuroradiological
Institute, Columbia Presbyterian Medical Center, in
New York. After his departure from Mallinckrodt Institute in 1971, he was named
radiologist-in-chief at Massachusetts General Hospital in
Boston and professor of radiology at Harvard University.
He became professor of radiology emeritus in 1988 and,
in 1989, Harvard created the
Juan M. Taveras Professorship.

He returned to the Dominican Republic to establish
and direct the Centra de
Diagnostico, Medicina Avanzada, Laboratorio y Telemedicina, at the Plaza de la Salud
in Santo Domingo. According to The Santo Domingo
News, "it is likely the Plaza
de la Salud will be renamed
in his honor."

American Roentgen Ray
Society Society (1988), and
the American Society of
Neuroradiology (1995). He
was a fellow of the American Heart Association
(Stroke Council) and of the
American College of Radiology and was the founding
editor of the American
Journal of Neuroradiology.

Taveras was often honored
for his medical expertise and
received a Gold Medal
Award from the Radiological
Society of North America
(1980), the Association of
University Radiologists
(1985), the American College
of Radiology (1985), the

He is survived by his wife
Mariana and his sons, and
stepsons. Memorial donations may be sent to the
Centro de Diagnostico in
Santo Domingo. 103
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IN MEMORIAM
Continued from page 31
We sadly report the
death of William
Powers, MD, former
director of MIR's Radiation
Oncology Center, who died
in Sarasota, Florida, on
November 17, 2001, from
cancer. He was 79.
Powers was a recognized
authority in treatment techniques for carcinoma of the
uterine cervix and in preoperative radiation therapy for
head and neck tumors. During his tenure at MIR, Powers played a key role in
radiation oncology breakthroughs, including the
development of the Cerrobend blocking system to
protect healthy tissue while
high doses of irradiation are
delivered to tumors and the
design and development of
high-energy linear accelerators. He and MIR cancer
biologist Leonard Tolmach,
PhD, first proved the existence of hypoxic cells in
tumors.
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Powers came to Mallinckrodt
Institute in 1952 as a diagnostic radiology resident and
joined the faculty in 1955 as
an instructor in radiology. He
served as director of the
Radiation Oncology Center
from 1965 to 1975, taking a
one-year sabbatical (September 1969 through August
1970) to work with the
National Cancer Institute, as
chief of Radiation Oncology,
Extramural Branch, on developing radiation therapy centers in the United States. He
left MIR in 1975 and was a
visiting professor at the University of Missouri, Columbia, and at the Thomas
Jefferson College of
Medicine in Philadelphia.
In 1978 he once again yielded
to the lure of academic
administration and accepted
the dual position of chairman
of the Department of Radiation Oncology at Wayne State
University and chief of radiation oncology at Harper Hospital in Detroit, Michigan,
where he remained until
his retirement in 1997.
Powers received Gold Medal
awards from the American
College of Radiology and
from the American Society
of Therapeutic Radiology
and Oncology. He was a

member of the President's
National Cancer Advisory
Board.

Following the 1994 Probstei
Lecture, Carlos Perez, MD, then-director of MIR's Radiation Oncoloi ■

He is survived by his wife
Linnea and five children.
Memorial donations may be
sent to the Department of
Radiation Oncology at Washington University School of
Medicine in St. Louis. EH3

ter, presided at the unveiling o
official William Powers portrait, wi
is currently displayed in the radi"
oncology conference room on th<
floor of the Institute. Bill and Lit,
Powers are shown with the portrai
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To Our Physician Colleagues
The Clinical Positron Emission Tomography (PET) Center on the
seventh floor of Mallinckrodt Institute of Radiology at Washington
University Medical Center is one of the Midwest's leading PET imaging
centers, offering comprehensive diagnostic testing for patient care. The
center has two PET scanners and is staffed by Mallinckrodt Institute
nuclear medicine physicians, who collectively have more than 145 years
of experience in nuclear medicine and PET.
Opened in 1988, the Clinical PET Center was one of the first facilities
worldwide to make the transition from research to medical practice and
now performs more than 20,000 nuclear medicine exams and over 2,100
PET procedures annually. Our PET specialists are full-time clinical
physicians of the Washington University School of Medicine and are
on staff at Barnes-Jewish and St. Louis Children's hospitals.
More information about PET imaging and scheduling can be accessed
online at http://gamma.wustl.edu/division/clinical-information.html
Call (314) 362-7418 to schedule PET examinations for your patients.

B Washington

University in StLouis

SCHOOL OF MEDICINE

Mm

Mallinckrodt Institute
of Radiology

1

MALLINCKRODT INSTITUTE OF RADIOLOGY

Address Service Requested
Send distribution changes or
address corrections to
Focal Spot editor
Mallinckrodt Institute
of Radiology at
Washington University
Campus Box 8131
510 South Kingshighway Blvd.
St. Louis, MO 63110
(314) 362-2866

Non-Profit Organizati
U.S. Postage i
St. Louis, Misso
Permit No. 25?

Editor and Writer
Vicki Kunkler
Contributing Writers
Candace O'Connor
Barbra Rodriguez
Christine Wayland
Photographers
William Middleton, MD
Tom Murry
Tim Parker
Michelle Wynn
Design
Purviance & Company
Marketing Communications
Printing
Scholin Brothers
Printing Company
Focal Spot magazine is
distributed three times annually.
© Mallinckrodt Institute of
Radiology, 2002

University in StLouis
SCHOOL OF MEDICINE
Mallinckrodt Institute
I of Radiology

J

r. i

/■

